期刊文献+

ST段抬高型心肌梗死患者经PCI后应用替格瑞洛与氯吡格雷的临床疗效及安全性比较 被引量:4

Comparison of clinical effect and safety of ticagrelor and clopidogrel applied in patients with ST segment elevation myocardial infarction after PCI
下载PDF
导出
摘要 目的:比较ST段抬高型心肌梗死患者经PCI后应用替格瑞洛与氯吡格雷的临床疗效及安全性。方法:收治行PCI治疗的ST段抬高型心肌梗死患者80例,分为两组。对照组给予氯吡格雷治疗,观察组给予替格瑞洛治疗,比较两组心血管事件发生率、左心功能。结果:观察组心血管事件发生率5.00%,低于对照组(P<0.05)。观察组LVEDV、LVESV、LVDs、LVEF均优于对照组(P<0.05)。结论:替格瑞洛治疗行PCI治疗的ST段抬高型心肌梗死患者可明显改善左心功能。 Objective:To compare the clinical effect and safety of ticagrelor and clopidogrel applied in patients with ST segmentelevation myocardial infarction after PCI.Methods:80cases of patients with ST segment elevation myocardial infarction treatedwith PCI were divided into two groups.The control group was treated with clopidogrel.The observation group was treated withticagrelor.The incidence of cardiovascular events and left ventricular function between groups were compared.Results:Theincidence of cardiovascular events in the observation group was5.00%,which was lower than that in the control group(P<0.05).The LVEDV,LVESV,LVDs and LVEF in the observation group were better than those in the control group(P<0.05).Conclusion:Ticagrelor in the treatment of patients with ST segment elevation myocardial infarction after PCI could improve the left ventricularfunction.
作者 金志文 Jin Zhiwen(The Second People's Hospital of Fuzhou City,Jiangxi Province344000)
出处 《中国社区医师》 2017年第6期14-14,16,共2页 Chinese Community Doctors
关键词 氯吡格雷 ST段抬高型心肌梗死 替格瑞洛 Clopidogrel ST segment elevation myocardial infarction Ticagrelor
  • 相关文献

参考文献4

二级参考文献26

  • 1Robert F. Storey,Kevin P. Bliden,Shankar B. Patil,Arun Karunakaran,Rosemary Ecob,Kathleen Butler,Renli Teng,Cheryl Wei,Udaya S. Tantry,Paul A. Gurbel.Incidence of Dyspnea and Assessment of Cardiac and Pulmonary Function in Patients With Stable Coronary Artery Disease Receiving Ticagrelor, Clopidogrel, or Placebo in the ONSET/OFFSET Study[J].Journal of the American College of Cardiology.2010(3)
  • 2Paul A. Gurbel,Kevin P. Bliden,Kathleen Butler,Mark J. Antonino,Cheryl Wei,Renli Teng,Lars Rasmussen,Robert F. Storey,Tonny Nielsen,John W. Eikelboom,Georges Sabe-Affaki,Steen Husted,Dean J. Kereiakes,David Henderson,Dharmendra V. Patel,Udaya S. Tantry.Response to Ticagrelor in Clopidogrel Nonresponders and Responders and Effect of Switching Therapies: The RESPOND Study[J].Circulation.2010(10)
  • 3Steg PG, James SK, Atar D,et al.ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation [ J ].Eur Heart J,2012, 33(20) : 2569 -2619.
  • 4Wallentin L, Becker RC, Budaj A, et al.Ticagrelor versus clopi-dogrel in patients with acute coronary syndromes [ J ].N Engl J Med, 2009,361(11) : 1045 -1057.
  • 5Kushner FG,Hand M,Smith SC Jr,et al.2009 focused updates :ACC/AHA guidelines for the management of patients with ST-ele-vation myocardial infarction ( updating the 2004 guideline and 2007 focused update) and ACC/AHA/SCAI Guidelines on Percutaneous Coronary Intervention (updating the 2005 Guideline and 2007 focused update): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines[ J].Circulation, 2009,120(22) : 2271 -2306.
  • 6O' Gara PT, Kushner FG, Ascheim DD, et al.2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines[J].Circulation, 2013,127(4) : e362 -425.
  • 7Levine GN, Bates ER, Blankenship JG, et al.2011 ACCF/ AHA/SCAI guideline for percutaneous coronary intervention.A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions[ J].J Am Coll Caixiiol, 2011,58(24): e44-122.
  • 8Anderson JL, Adams CD,Antman EM, et al.2012 ACCF/AHA focused update incorporated into the ACCF/AHA 2007 guidelines for the mangement of patients with unstable angina/non-ST-eleva-tion myocardial infarction: a report of the American College of Cardiology Foundation/ American Heart Association Task Force on Practice Guidelines [ J ].J Am Coll Cardiol, 2013 , 61 (23): el79 - 347.
  • 9James S, Akerblom A, Cannon CP, et al.Comparison of ticagrelor ,the first reversible oral P2Y ( 12 ) receptor antagonist, with clopidogrel in patients with acute coronary syndromes : Rationale ,design,and baseline characteristics of the PLATelet inhibition and patient Outcomes ( PLATO) trial [ J].Am Heart J,2009, 157(4) : 599 -605.
  • 10Andereon JL, Adams CD, Antman EM, et al.2011 ACCF/AHA focused update incorporated into the ACC/AHA 2007 guidelines for the management of patients with unstable angina/ non-ST-eleva-tion myocardial infarction : a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines[ J ].Circulation, 2011,123(18): e426 -579.

共引文献192

同被引文献28

引证文献4

二级引证文献62

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部